Loading…
New: tenders and results on WhatsApp
New: Find tenders, results and companies on WhatsApp, by text or voice note
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | MAMMOTH LIFESCIENCES LLP | Awarded | 1 | ₹27,552 |
| 2 | Schedule 2 | PRATHMESH DISTRIBUTOR | Awarded | 1 | ₹2,628 |
| 3 | Schedule 3 | NEW LIFE MEDICOS | Awarded | 1 | ₹5,135.60 |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
8 Aug 2025, 10:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Cilnidipine 20 Mg Tab
Cilostazol 50mg Tab
Clindamycin 300 Mg Cap
8130701
GEM/2025/B/6489454
Two Packet Bid
Cilnidipine 20 Mg Tab
15 days
Central Delhi
Item wise evaluation
PRODUCT_CUSTOM
7 documents required · 7 mandatory
3 yrs
10%
Exempted
8 Aug 2025
24 Jul 2025
8 Aug 2025
Cilnidipine 20 Mg Tab
Cilostazol 50mg Tab
Clindamycin 300 Mg Cap
CLINDAMYCIN 300 MG CAP
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_8130701.pdf
GEM_BID
specification_re_64_2025-07-23-15-13-58_cb372f37ffed2d54343bf709b7444785.pdf
SPECIFICATION
specification_re_64_2025-07-23-15-15-41_ac264b82580f3597afd431ea86e8762b.pdf
SPECIFICATION
specification_re_64_2025-07-23-15-17-02_a72f048007a3027ba0ca2654f0631d32.pdf
SPECIFICATION
newatc_11ee55d8-420b-40f8-a2481753328495813_tejasvagupta.865n@gov.in.pdf
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .